Zhou H, Coffin CM, Perkins SL, Tripp SR, Liew M, Viskochil DH
Having a weight management plan in place may help you maintain a healthy body weight beyond your treatment
Tirzepatide is a dual-agonist , meaning it works by targeting two hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Retatrutide is a triple-agonist , meaning it targets three hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Glucagon: affects energy use and fat metabolism Early studies show that retatrutide may be more successful than tirzepatide at managing diabetic kidney disease, as well as for weight control, while tirzepatide may be better at managing blood glucose
Q: Can it be used by teenagers or adults
The appetite suppression timeline for GLP-1 medications gives context for when reduced food intake typically begins affecting nutrient status
Timeline: When Diarrhea Starts and How Long It Lasts Most patients first notice loose stools or increased bowel frequency within the first week of starting semaglutide or during dose increases
